Ignite Creation Date:
2025-12-24 @ 4:05 PM
Ignite Modification Date:
2026-01-28 @ 2:23 AM
Study NCT ID:
NCT02229266
Status:
TERMINATED
Last Update Posted:
2021-08-16
First Post:
2014-08-28
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Randomised Controlled Phase-2 Trial to Determine the Efficacy of Adoptive Immunotherapy With NK Cells in High-risk AML
Sponsor:
Technische Universität Dresden
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-09
Start Date Type:
None
Primary Completion Date:
2017-04-22
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-04-22
Completion Date Type:
ACTUAL
First Submit Date:
2014-08-28
First Submit QC Date:
None
Study First Post Date:
2014-09-01
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-08-10
Last Update Post Date:
2021-08-16
Last Update Post Date Type:
ACTUAL